London, United Kingdom
London, United Kingdom

Time filter

Source Type

Vet Innovations' mission is to dramatically improve the lives of pets, pet parents, and veterinarians through groundbreaking technology to reduce pet obesity and enhance wellness.  PortionPro Rx is the only professional-grade veterinary device that automatically dispenses timed, portion-controlled food to a specific pet while denying access to food to all other pets, a key aspect of a successful veterinarian-prescribed wellness and weight management program. This innovative solution received extraordinary response at meetings of the NAVC (North American Veterinary Community), WVC (Western Veterinary Conference), and AAHA (American Animal Hospital Association) and has now attracted the attention of the 2017 Kansas City Animal Health Investment Forum, where Vet Innovations, the maker of PortionPro Rx, is one of only 18 companies selected to present. "It's quite an honor to be selected to present at this prestigious annual event," says Bob LaRoche, president and chief executive officer of Vet Innovations. "This invitation confirms the importance of PortionPro Rx in fulfilling the significant need to reverse the epidemic of pet obesity in multi-­pet households in the United States, Canada, and beyond." It is a sad but true statistic: more than 50% of all cats and dogs in the U.S.—nearly 100 million pets—are either overweight or obese, according to the Association for Pet Obesity Prevention (APOP). And alarming new data indicates a trend toward super-obesity. In cats, the obesity rate climbed from 22% in 2009 to 28% in 2015. In dogs, the obesity rate rose from 9% in 2009 to 20% in 2015.1 Furthermore, Banfield, the largest operator of veterinary hospitals in America, has declared pet obesity an epidemic and has sounded a rallying cry to the profession and industry to redouble efforts to fight those extra pounds and reduce the risk of the more than 20 health conditions associated with overweight and obese animals.2 This problem is estimated to affect more than 53 million U.S. households, where turf battles and food stealing often complicate pet mealtimes. To feed individual diets in a house full of pets, pet parents must closely monitor and/or separate pets at mealtimes, which can be an inconvenient, stressful, chaotic, and ultimately ineffective exercise. PortionPro Rx offers a breakthrough solution designed to solve veterinarians' frustrations when it comes to pet parent compliance. The product uniquely integrates patented Pet Field Communication™ (PFC) technology to identify individual pets and control access to food. "I came up with the concept behind the PortionPro Rx because I saw so many clients every day who were struggling with taking weight off their pets and realized how challenging and stressful it was to comply with and adhere to my recommendations," says Vet Innovations expert Dr. Troy Hexter, who is also a practicing veterinarian in Connecticut. "It has been beyond my expectations to see the incredible reception our product has received and hear how our access control technology will help so many pets and their families." PortionPro Rx will be available in late 2017 and only through veterinarians. Vet Innovations' distribution partner VetSource will deliver PortionPro Rx directly to pet parents throughout the U.S. Vet Innovations is exploring international distribution options to meet global demand. Vet Innovations' mission is to dramatically improve the lives of pets, pet parents, and veterinarians through groundbreaking technology to reduce pet obesity and enhance wellness. The company's proprietary robotic-based electromagnetic technology automatically identifies individual pets to control their access to devices such as the PortionPro Rx and other future products under development. Visit portionprorx.com to learn more and see how this first-of-its-kind device works, or contact Vet Innovations directly. Learn more at vetinnovations.com. Follow us on Twitter (@vetinnovations) and Linked In. Or email us at info@vetinnovations.com.


The present invention provides novel stem cell compositions having significant therapeutic and practical advantages, as well as methods of preparing and using such compositions for the treatment and prevention of injury and disease in patients. The invention may be applied to stem cell populations isolated from a wide variety of animals, including humans, and tissues. In particular applications, the invention is used to prepare a stem cell composition from a collagen-based tissue, such as adipose tissue, isolated from a patient, and the stem cell composition is subsequently provided to a site of actual or potential injury in the patient. The invention further includes related kits comprising the stem cell compositions, which are remarkably stable and retain viability and efficacy during storage and shipment.


News Article | February 27, 2017
Site: www.prnewswire.com

BURLINGTON, Conn., Feb. 27, 2017 /PRNewswire/ -- How do you successfully feed a therapeutic diet to an individual pet in a multi-pet home? The answer to this question, the unique new prescribable solution PortionPro Rx, was previewed with virtually universal accolades by more than 900...


Jordan W.H.,Vet Inc.
Toxicologic pathology | Year: 2011

For many pathologists, neuropathology is intimidating. Practical approaches for nervous tissue histologic evaluations to meet both routine and advanced study designs can lead to rewarding neuropathology efforts. Cost-effective, high-quality histologic evaluations can occur if animals are exsanguinated quickly, brains removed carefully to maintain structural integrity and avoid dark neuron artifact, immersion-fixed quickly and thoroughly, and trimmed and processed to consistently survey multiple areas. While brightfield examination of H&E-stained sections is generally sufficient for survey evaluations, epifluorescent assessment of neuronal autofluorescence facilitates recognition of neurodegeneration in H&E-stained sections. Fluoro-Jade B or specialized immunohistochemical stains may be required to answer specific questions. Evaluations require that both technical staff and pathologists have a working knowledge of a few easily identified neuroanatomic landmarks and familiarity with use of a detailed brain atlas. At least four coronal sections should be routinely surveyed from young adult rats, with evaluation of comparable areas in other laboratory animal species. This number should be at least doubled if there is reason to suspect morphologic changes in the CNS. This article focuses on technical details of efficient specimen preparation for neuropathologic evaluations involving relatively large numbers of rodents, as well as a practical approach to basic neuroanatomic site identification.


Trademark
Vet Inc. | Date: 2017-01-26

automated pet feeder.


Trademark
Vet Inc. | Date: 2017-01-26

automated pet feeder.


Trademark
Vet Inc. | Date: 2017-01-26

automated pet feeder.


Pfc

Trademark
Vet Inc. | Date: 2017-01-26

automated pet feeder.


Methods for improving the health of agricultural poultry are provided. For example, methods including selecting specific bacteria to form a probiotic for the administration with coccidiosis vaccines for the reduction of adverse effects associated with the coccidiosis vaccines are disclosed. In accordance with various aspects of the present disclosure, a bacterial isolate, probiotic and or treatment may be obtained by novel screening methods resulting in products that are advantageously administered with or about the same time as a coccidiosis vaccine.


The present invention provides novel stem cell compositions having significant therapeutic and practical advantages, as well as methods of preparing and using such compositions for the treatment and prevention of injury and disease in patients. The invention may be applied to stem cell populations isolated from a wide variety of animals, including humans, and tissues. In particular applications, the invention is used to prepare a stem cell composition from a collagen-based tissue, such as adipose tissue, isolated from a patient, and the stem cell composition is subsequently provided to a site of actual or potential injury in the patient. The invention further includes related kits comprising the stem cell compositions, which are remarkably stable and retain viability and efficacy during storage and shipment.

Loading Vet Inc. collaborators
Loading Vet Inc. collaborators